Filed: 2/11/2026ACC: 0001193125-26-045633
π What this filing means
SANOFI filed this quarterly 13FβHR report disclosing 8 equity positions with a total reported market value of $310.41M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
8
Positions
$310.41M
Total AUM (reported)
25.74M
Total Shares
Allocation by class
COM$246.36M79.4%
COM NEW$46.24M14.9%
CLASS A COM$17.82M5.7%
Portfolio Concentration
Top 3$234.68M75.6%
4β10$75.73M24.4%
Top 3 weight
75.6%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 25.74M
Sole
Full voting authority
25.74M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole8
Shared0
Other0
Dominant voting typeSole Β· 100.0% of voting shares
Institutional Holdings8
Rows:
MeiraGTx Holdings plc
SOLEShares12.20M
TypeSH
Market value$96.97M
31.24%
Sole
12.20M
Shared
0.00
None
0.00
Inhibrx Biosciences, Inc.
SOLEShares1.16M
TypeSH
Market value$91.48M
29.47%
Sole
1.16M
Shared
0.00
None
0.00
Novavax
SOLEShares6.88M
TypeSH
Market value$46.24M
14.90%
Sole
6.88M
Shared
0.00
None
0.00
AnaptysBio
SOLEShares821.92K
TypeSH
Market value$39.85M
12.84%
Sole
821.92K
Shared
0.00
None
0.00
Immuneering Corp
SOLEShares2.71M
TypeSH
Market value$17.82M
5.74%
Sole
2.71M
Shared
0.00
None
0.00
MapLight Therapeutics Inc.
SOLEShares912.04K
TypeSH
Market value$16.02M
5.16%
Sole
912.04K
Shared
0.00
None
0.00
Eledon
SOLEShares814.98K
TypeSH
Market value$1.23M
0.40%
Sole
814.98K
Shared
0.00
None
0.00
Q32 Bio Inc.
SOLEShares244.08K
TypeSH
Market value$810.4K
0.26%
Sole
244.08K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting β Sole | Shared | None |
|---|---|---|---|---|---|---|---|
MeiraGTx Holdings plcSOLE | COM | 12.20M | SH | $96.97M 31.24% | 12.20M | 0.00 | 0.00 |
Inhibrx Biosciences, Inc.SOLE | COM | 1.16M | SH | $91.48M 29.47% | 1.16M | 0.00 | 0.00 |
NovavaxSOLE | COM NEW | 6.88M | SH | $46.24M 14.90% | 6.88M | 0.00 | 0.00 |
AnaptysBioSOLE | COM | 821.92K | SH | $39.85M 12.84% | 821.92K | 0.00 | 0.00 |
Immuneering CorpSOLE | CLASS A COM | 2.71M | SH | $17.82M 5.74% | 2.71M | 0.00 | 0.00 |
MapLight Therapeutics Inc.SOLE | COM | 912.04K | SH | $16.02M 5.16% | 912.04K | 0.00 | 0.00 |
EledonSOLE | COM | 814.98K | SH | $1.23M 0.40% | 814.98K | 0.00 | 0.00 |
Q32 Bio Inc.SOLE | COM | 244.08K | SH | $810.4K 0.26% | 244.08K | 0.00 | 0.00 |